pravastatin has been researched along with interleukin-8 in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 4 (66.67) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Casey, LC; Rosenson, RS; Tangney, CC | 1 |
Davis, PM; Kiener, PA; Kowala, M; Murray, JL; Rankin, BM; Youssef, S | 1 |
Kishida, M; Kobayashi, M; Nakamura, N; Nobata, Y; Sato, A; Takata, M; Temaru, R; Urakaze, M; Yamazaki, K | 1 |
Ikeda, U; Ito, T; Shimada, K; Yamamoto, K | 1 |
Benderitter, M; Gaugler, MH; Squiban, C; Vandamme, M; Vereycken-Holler, V; Vozenin-Brotons, MC | 1 |
Allijn, IE; Beukelman, KJ; de Winther, MP; Quarles van Ufford, LC; Schiffelers, RM; Storm, G; Vaessen, SF | 1 |
6 other study(ies) available for pravastatin and interleukin-8
Article | Year |
---|---|
Inhibition of proinflammatory cytokine production by pravastatin.
Topics: Aged; Aged, 80 and over; Anticholesteremic Agents; Cholesterol; Cytokines; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Inflammation Mediators; Interleukin-1; Interleukin-6; Interleukin-8; Male; Middle Aged; Pravastatin; Receptors, Interleukin-1; Tumor Necrosis Factor-alpha | 1999 |
Stimulation of inflammatory responses in vitro and in vivo by lipophilic HMG-CoA reductase inhibitors.
Topics: Animals; Anticholesteremic Agents; Cell Line; Chemokine CCL2; Cholesterol; Cytokines; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Inflammation; Interleukin-1; Interleukin-8; Leukocytes; Male; Mice; Mice, Inbred C57BL; Monocytes; Pravastatin; Reactive Oxygen Species; Tumor Necrosis Factor-alpha | 2001 |
Pravastatin suppresses the interleukin-8 production induced by thrombin in human aortic endothelial cells cultured with high glucose by inhibiting the p44/42 mitogen activated protein kinase.
Topics: Anticholesteremic Agents; Aorta; Blotting, Western; Cells, Cultured; DNA-Binding Proteins; Dose-Response Relationship, Drug; Endothelium, Vascular; Gene Expression Regulation; Glucose; Humans; I-kappa B Proteins; Interleukin-8; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinases; NF-KappaB Inhibitor alpha; Phosphorylation; Plant Proteins; Pravastatin; ras Proteins; RNA, Messenger; Tetradecanoylphorbol Acetate; Thrombin; Transcription Factor AP-1 | 2001 |
Regulation of interleukin-8 expression by HMG-CoA reductase inhibitors in human vascular smooth muscle cells.
Topics: Analysis of Variance; Cells, Cultured; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Interleukin-8; Muscle, Smooth, Vascular; Pravastatin; Probability; Pyridines; RNA, Messenger; Sensitivity and Specificity | 2002 |
Pravastatin limits endothelial activation after irradiation and decreases the resulting inflammatory and thrombotic responses.
Topics: Arteriosclerosis; Cells, Cultured; Chemokine CCL2; Dose-Response Relationship, Drug; Endothelial Cells; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intercellular Adhesion Molecule-1; Interleukin-6; Interleukin-8; Mevalonic Acid; NF-kappa B; Pravastatin; Radiotherapy; Thrombosis | 2005 |
Head-to-Head Comparison of Anti-Inflammatory Performance of Known Natural Products In Vitro.
Topics: Acetophenones; Animals; Anti-Inflammatory Agents; Berberine; Biological Products; Blood Platelets; Caco-2 Cells; Catechin; Cell Line; Curcumin; Humans; Interleukin-6; Interleukin-8; Macrophages; Mice; Neutrophils; Platelet Activation; Pravastatin; Prednisolone; Primary Cell Culture; Reactive Oxygen Species; Stilbenes; Tumor Necrosis Factor-alpha | 2016 |